Report Detail
Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019
- RnM3839053 |
- 28 November, 2019 |
- Global |
- 279 Pages |
- GlobalData |
- Medical Devices & Consumables
Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Test Kits currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Test Kits pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hepatitis Test Kits under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Test Kits and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Test Kits under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
- 1.1 List of Tables 8
- 1.2 List of Figures 13
2 Introduction 14
- 2.1 Hepatitis Test Kits Overview 14
3 Products under Development 15
- 3.1 Hepatitis Test Kits - Pipeline Products by Stage of Development 15
- 3.2 Hepatitis Test Kits - Pipeline Products by Segment 16
- 3.3 Hepatitis Test Kits - Pipeline Products by Territory 17
- 3.4 Hepatitis Test Kits - Pipeline Products by Regulatory Path 18
- 3.5 Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 19
4 Hepatitis Test Kits - Pipeline Products under Development by Companies 20
- 4.1 Hepatitis Test Kits Companies - Pipeline Products by Stage of Development 20
- 4.2 Hepatitis Test Kits - Pipeline Products by Stage of Development 22
5 Hepatitis Test Kits Companies and Product Overview 26
- 5.1 Abbott Diagnostics Company Overview 26
- 5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 26
- 5.2 Alderon Biosciences Inc Company Overview 29
- 5.2.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
- 5.3 AutoGenomics Inc Company Overview 30
- 5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
- 5.4 AXO Science SAS Company Overview 32
- 5.4.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 32
- 5.5 Beckman Coulter Inc Company Overview 33
- 5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 33
- 5.6 Biokit SA Company Overview 34
- 5.6.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 34
- 5.7 Biomagnetics Diagnostics Corp Company Overview 37
- 5.7.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 37
- 5.8 Bio-Rad Laboratories Inc Company Overview 38
- 5.8.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 38
- 5.9 Boditech Med Inc Company Overview 39
- 5.9.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 39
- 5.10 CeMines, Inc. (Inactive) Company Overview 42
- 5.10.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
- 5.11 Cepheid Company Overview 43
- 5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 43
- 5.12 China Medical Technologies Inc (Inactive) Company Overview 44
- 5.12.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
- 5.13 Co-Diagnostics Inc Company Overview 45
- 5.13.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
- 5.14 Corgenix Medical Corp Company Overview 46
- 5.14.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 46
- 5.15 Da An Gene Co Ltd Company Overview 47
- 5.15.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
- 5.16 Diagnostics for the Real World (Europe) Ltd Company Overview 50
- 5.16.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
- 5.17 DiaSorin SpA Company Overview 51
- 5.17.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 51
- 5.18 D-Kimia, LLC. Company Overview 54
- 5.18.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 54
- 5.19 DNAE Group Holdings Ltd Company Overview 55
- 5.19.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
- 5.20 Ecoli sro Company Overview 56
- 5.20.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview 56
- 5.21 Ferrer inCode SL Company Overview 59
- 5.21.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 59
- 5.22 Fujirebio Diagnostics Inc Company Overview 60
- 5.22.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
- 5.23 Genome Diagnostics Pvt. Ltd. Company Overview 68
- 5.23.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
- 5.24 HealthTell Inc Company Overview 69
- 5.24.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 69
- 5.25 Hepron Molecular Lab Inc Company Overview 71
- 5.25.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 71
- 5.26 Hologic Inc Company Overview 72
- 5.26.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 72
- 5.27 Imperial College London Company Overview 73
- 5.27.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 73
- 5.28 LifeAssay Diagnostics (Pty) Ltd Company Overview 74
- 5.28.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
- 5.29 MedMira Inc Company Overview 76
- 5.29.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 76
- 5.30 Medosome Biotec LLC Company Overview 77
- 5.30.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview 77
- 5.31 Monogram Biosciences Inc Company Overview 78
- 5.31.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 78
- 5.32 NanoDiagX Company Overview 79
- 5.32.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview 79
- 5.33 Ortho-Clinical Diagnostics Inc Company Overview 80
- 5.33.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 80
- 5.34 Paramedical Srl Company Overview 85
- 5.34.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 85
- 5.35 ProteinLogic Ltd Company Overview 91
- 5.35.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
- 5.36 Qiagen NV Company Overview 92
- 5.36.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 92
- 5.37 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 94
- 5.37.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 94
- 5.38 Roche Diagnostics International Ltd Company Overview 95
- 5.38.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
- 5.39 Sansure Biotech Inc Company Overview 103
- 5.39.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 103
- 5.40 Seegene Inc Company Overview 106
- 5.40.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 106
- 5.41 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 109
- 5.41.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109
- 5.42 Siemens Healthcare Diagnostics Inc Company Overview 111
- 5.42.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 111
- 5.43 Siemens Healthineers AG Company Overview 114
- 5.43.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 114
- 5.44 Stanford University Company Overview 118
- 5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 118
- 5.45 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 119
- 5.45.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 119
- 5.46 Sysmex Corp Company Overview 121
- 5.46.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 121
- 5.47 TBG Diagnostics Ltd Company Overview 123
- 5.47.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 123
- 5.48 University Medical Center Hamburg-Eppendorf Company Overview 125
- 5.48.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview 125
- 5.49 University of British Columbia Company Overview 126
- 5.49.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 126
- 5.50 University of Texas Medical Branch at Galveston Company Overview 127
- 5.50.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 127
- 5.51 University of Warwick Company Overview 128
- 5.51.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 128
- 5.52 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 129
- 5.52.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
- 5.53 Xiamen Zeesan Biotech Co.,Ltd Company Overview 130
- 5.53.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 130
6 Hepatitis Test Kits- Recent Developments 131
- 6.1 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 131
- 6.2 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin 133
- 6.3 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 133
- 6.4 Nov 06, 2019: OraSure announces 2019 third quarter financial results 134
- 6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 136
- 6.6 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 138
- 6.7 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 139
- 6.8 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 141
- 6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 142
- 6.10 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 143
7 Appendix 276
- 7.1 Methodology 276
- 7.2 About GlobalData 279
- 7.3 Contact Us 279
Summary:
Get latest Market Research Reports on Hepatitis Test Kits. Industry analysis & Market Report on Hepatitis Test Kits is a syndicated market report, published as Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Hepatitis Test Kits market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
